TY - JOUR T1 - EFFICACY AND SAFETY OF CARFILZOMIB, DEXAMETHASONE, DARATUMUMAB TWICE-WEEKLY AT 56 MG/M2 AND ONCE-WEEKLY AT 70 MG/M2 IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: CROSS-STUDY COMPARISON OF CANDOR AND MMY1001 JO - Hematology, Transfusion and Cell Therapy T2 - AU - Leleu,X. AU - Beksac,M. AU - Chou,T. AU - Dimopoulos,M.A. AU - Yoon,S. AU - Prince,H.M. AU - Chari,A. AU - Oriol,A. AU - Siegel,D.S.D. AU - Khurana,M. AU - Qi,M. AU - Obreja,M. AU - Pour,L. AU - Shelekhova,T. SN - 25311379 M3 - 10.1016/j.htct.2020.10.431 DO - 10.1016/j.htct.2020.10.431 UR - http://www.htct.com.br/en-efficacy-and-safety-of-carfilzomib-articulo-S2531137920307173 ER -